Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Valme University Hospital
Hospital Universitario Reina Sofia
Hospital Universitario Virgen de la Victoria
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Hospital Regional de Malaga
Hospital Torrecárdenas
Complejo Hospitalario Universitario de Huelva
Hospital Universitario Puerta del Mar
Hospital Universitario Virgen Macarena
Hospital La Línea
Complejo Hospitalario de Jaén
Hospital Universitario Puerto Real
Hospital Universitario de Canarias
Hospital Poniente
Hospital Universitario Central de Asturias
Hospital Álvaro Cunqueiro
Hospital Universitario Virgen de la Arrixaca
Hospital Universitario de Gran Canaria
Information provided by (Responsible Party):
José A. Mira Escarti, Valme University Hospital Identifier:
First received: January 6, 2014
Last updated: October 14, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)